Topics

Lodo Therapeutics Corporation Company Profile

15:19 EDT 19th September 2019 | BioPortfolio

Lodo Therapeutics Corporation is a drug discovery and development company focused on the creation of novel therapeutics derived from nature that will impact patients around the world. The company was established to pursue the scientific vision of Dr. Sean Brady, head of The Rockefeller University's Laboratory of Genetically Encoded Small Molecules. Lodo Therapeutics identifies and produces bioactive natural products directly from the microbial DNA sequence information contained in soil. Information encoded in bacterial genomes, not experimental serendipity, drives the company’s discovery of new medicines. Not constrained by traditional culture-based approaches to natural products drug discovery, Lodo Therapeutics has unlocked a vast trove of overlooked compounds evolutionarily selected for processes essential for life and with significant potential in the treatment of drug-resistant microbial infections and cancers


News Articles [1046 Associated News Articles listed on BioPortfolio]

ORION CORPORATION: ACQUISITION OF OWN SHARES 03.05.2019

Orion Corporation NOTIFICATION 03.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 03.05.2019 Date 03.05.201...

ORION CORPORATION: ACQUISITION OF OWN SHARES 10.05.2019

Orion Corporation NOTIFICATION 10.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 10.05.2019 Date 10.05.201...

ORION CORPORATION: ACQUISITION OF OWN SHARES 09.05.2019

Orion Corporation NOTIFICATION 09.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 09.05.2019 Date 09.05.20...

ORION CORPORATION: ACQUISITION OF OWN SHARES 07.05.2019

Orion Corporation NOTIFICATION 07.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 07.05.2019 Date 07.05.2019...

ORION CORPORATION: ACQUISITION OF OWN SHARES 08.05.2019

Orion Corporation NOTIFICATION 08.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 08.05.2019 Date 08.05.2019  ...

ORION CORPORATION: ACQUISITION OF OWN SHARES 13.05.2019

Orion Corporation NOTIFICATION 13.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 13.05.2019  Date 13....

ORION CORPORATION: ACQUISITION OF OWN SHARES 02.05.2019

Orion Corporation NOTIFICATION 02.05.2019 at 19:13 ORION CORPORATION: ACQUISITION OF OWN SHARES 02.05.2019 Date 02....

ORION CORPORATION: ACQUISITION OF OWN SHARES 06.05.2019

Orion Corporation NOTIFICATION 06.05.2019 at 18:30 ORION CORPORATION: ACQUISITION OF OWN SHARES 06.05.2019 Date 06.05.2...

PubMed Articles [443 Associated PubMed Articles listed on BioPortfolio]

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

CRISPR: a promising tool for lipid physiology and therapeutics.

The purpose is to review recent progress in applying the CRISPR/Cas9 system to lipid metabolism and therapeutics.

Advancing Nucleic Acid Therapeutics by Setting Uniform Standards for Experimental Controls.

Antiglaucoma EP Agonists: A Long Road That Led Somewhere.

For >2 decades, EP agonists have been the subject of antiglaucoma research and development by scientists in industry and academia around the world. The road has led to the recent approval of the first...

Glycan analysis for protein therapeutics.

Glycosylation can be a critical quality attribute for protein therapeutics due to its extensive impact on product safety and efficacy. Glycan characterization is important in the process of protein dr...

Clinical Trials [188 Associated Clinical Trials listed on BioPortfolio]

Leukotriene Polymorphisms and Montelukast Response - Ancillary to LoDo Trial

To elucidate the mechanisms underlying inter-patient variation in response to montelukast, a drug for asthma.

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

The purpose of the study is to assess long-term side effects from subjects who receive a Fate Therapeutics genetically modified NK cell product. Subjects who previously took part in a Fate...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Dobutamine Stress Echocardiography in Cardiac Resynchronization Therapy (CRT) Patients Selection

While cardiac resynchronization therapy (CRT) has a well demonstrated therapeutic effect in selected patients with advanced heart failure (HF) on optimized drug therapy, non-responder rate...

Companies [1550 Associated Companies listed on BioPortfolio]

Lodo Therapeutics Corporation

Lodo Therapeutics Corporation is a drug discovery and development company focused on the creation of novel therapeutics derived from nature that will impact patients around...

Wellstat Therapeutics Corporation

Wellstat Therapeutics™ Corporation is a privately-held biopharmaceutical company located in Gaithersburg, Maryland. Dedicated to the discovery, development and commercialization of innovative therap...

Toshiba Corporation

Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...

InVivo Therapeutics Corporation

InVivo Therapeutics Corporation is a Cambridge, MA medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in indiv...

Bruker Daltonics

Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...

More Information about "Lodo Therapeutics Corporation" on BioPortfolio

We have published hundreds of Lodo Therapeutics Corporation news stories on BioPortfolio along with dozens of Lodo Therapeutics Corporation Clinical Trials and PubMed Articles about Lodo Therapeutics Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lodo Therapeutics Corporation Companies in our database. You can also find out about relevant Lodo Therapeutics Corporation Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...


Corporate Database Quicklinks



Searches Linking to this Company Record